Group items tagged

The purpose of the Mentored Quantitative Research Career Development Award (K25) is to attract to NIH-relevant research those investigators whose quantitative science and engineering research has thus far not been focused primarily on questions of health and disease. The K25 award will provide support and "protected time" for a period of supervised study and research for productive professionals with quantitative (e.g., mathematics, statistics, economics, computer science, imaging science, informatics, physics, chemistry) and engineering backgrounds to integrate their expertise with NIH-relevant research. This Funding Opportunity Announcement (FOA) is designed specifically for applicants proposing research that does not involve leading an independent clinical trial, a clinical trial feasibility study, or an ancillary clinical trial. Applicants to this FOA are permitted to propose research experience in a clinical trial led by a mentor or co-mentor. Applicants proposing a clinical trial or an ancillary clinical trial as lead investigator, should apply to the companion FOA ().

The purpose of the NIH Mentored Research Scientist Development Award (K01) is to provide support and protected time (three to five years) for an intensive, supervised career development experience in the biomedical, behavioral, or clinical sciences leading to research independence. Although all of the participating NIH Institutes and Centers (ICs) use this support mechanism to support career development experiences that lead to research independence, some ICs use the K01 award for individuals who propose to train in a new field or for individuals who have had a hiatus in their research career because of illness or pressing family circumstances. Other ICs offer separate K01 FOAs intended to increase research workforce diversity.

This funding opportunity announcement (FOA) seeks to leverage data from existing basic, clinical, and intervention research on suicide risk and behaviors as well as social media and healthcare records data, by encouraging the integration of existing data sets for novel secondary analyses aimed at identifying potential biological, experiential, and other predictors and moderators of suicide risk. The use of dimensional variables and inclusion of multiple levels of analyses is particularly encouraged. A secondary goal of this FOA is to support innovative projects that will generate foundational work for research studies on suicide-related behaviors that inform a Research Domain Criteria (RDoC) approach in this area.

A single grant of up to $8,000 grant will be awarded to support novel basic and clinical research on anxiety and anxiety related disorders conducted by graduate students and early career researchers. To be eligible, applicants must be a graduate student or early-career researcher (no more than ten years postdoctoral); be affiliated with a nonprofit charitable, educational, or scientific institution, or a governmental entity operating exclusively for charitable and educational purposes; have a demonstrated knowledge of anxiety and anxiety research, either basic or clinical; and have demonstrated competence and the capacity to execute the proposed work.

his Funding Opportunity Announcement (FOA) invites applications for specialized Alcohol Research Centers using the P50 mechanism. The overall purpose of the NIAAA Alcohol Research Center program is to provide leadership in conducting and fostering interdisciplinary, collaborative research on a wide variety of topics relevant to the Institutes mission. These topics include, but are not limited to: the nature, etiology, genetics, diagnosis, treatment, and prevention of alcohol use disorders and their biomedical, psychosocial, and economic consequences across the lifespan. Centers also are regional or national resources that contribute to the development of new research methods, technologies and approaches that sustain innovative goal-directed research.

he purpose of this FOA is to solicit applications to examine the impact of behavioral interventions within the context of states plans for use of the SAMHSA Opioid STR grant funds authorized under the 21st Century Cures Act. Applications are encouraged for studies that examine the impact of interventions such as mindfulness meditation, cognitive behavioral therapy, or multi-disciplinary rehabilitation for primary or secondary prevention for opioid use disorder (OUD) or as an adjunct to medication assisted treatment (MAT) of OUD. Applications that emphasize treatment of the comorbidity of OUD and chronic pain are of particular interest.

The Behavioral Risk Factor Surveillance System (BRFSS) is the primary source of state-specific surveillance information about health risk behaviors and health status among the states’ resident population. BRFSS is a state-based system of random digit-dialing telephone and mixed-mode health surveys that target non-institutionalized adults, ages 18 years and older. CDC will work with awardees to develop and implement jurisdiction-specific evaluation plans and ensure accurate evaluation and performance measurement reporting.

The Ohio Opioid Abuse, Prevention and Treatment Technology Initiative is to accelerate the development and commercialization of promising new products (or adaptations or modifications) in the categories of medical devices, diagnostics, pharmaceuticals, and health technology.  They should meaningfully address one or more issues associated with the drug crisis driven by use, misuse, abuse and the addictive potential of opioids. Specifically, projects must contribute to near term tangible solutions associated with addiction prevention, treatment and overdose intervention. Technology and products that enable safe and effective treatment of acute and chronic pain without the use of opioids are encouraged. 

The Ohio Opioid Technology Challenge is a prize competition seeking innovative solutions to reduce morbidity and mortality associated with opioid use and addiction by addressing prevention, treatment, and overdose response and avoidance. This will be a multi-phase competition with escalating prize amounts associated with progressive levels of solution development. Each phase of the competition will be associated with highly visible events to showcase ideas, announce awards and details of the next phase of the competition, and generally provide a public forum for the discussion of the opioid crisis in Ohio.  The Ohio Development Services Agency is seeking an experienced Competition Manager for this program. 

1) link Prescription Drug Monitoring Program (PDMP) information to opioid-related drug overdose deaths, 2) complete abstraction and entry of information from death certificate and ME/C reports on opioid-related fatalities into the State Unintentional Drug Overdose Reporting System (SUDORS) within 3 to 6 months, 3) improve scope and/or data quality collected on emergency department (ED) drug overdose visits, 4) improve timeliness and reporting of emergency medical services (EMS) data, and/or 5) propose innovative projects that fall within the scope of the ESOOS cooperative agreement and are approved by CDC.

The SBIR program, as established by law, is intended to meet the following goals: stimulate technological innovation in the private sector; strengthen the role of small business in meeting Federal research or research and development (R/R&D) needs; increase the commercial application of Federally-supported research results; foster and encourage participation by socially and economically disadvantaged small business concerns and women-owned business concerns in the SBIR program; and improve the return on investment from Federally-funded research for economic and social benefits to the Nation.

Priority will be given to applications that show capacity to design and implement quasi-experimental or experimental studies (using primary and/or secondary data sources) with theory-driven research questions and methodologies that will yield important information about the impact of the arts within the selected topic area. Competitive applications will take into account any extant research that serves as a basis for a theoretical framework and helps to motivate the proposed project. We also welcome novel and promising research approaches, such as rigorous analyses of organizational or social networks and/or social media data. In addition, we are interested in translational research that moves scientific evidence toward the development, testing, and standardization of new arts-related programs, practices, models, or tools that can be used easily by other practitioners and researchers.

Program Description: In recent years, the National Endowment for the Arts' research agenda has focused on yielding new knowledge about the value and impact of the arts. Through the National Endowment for the Arts Research Labs (NEA Research Labs), we seek to extend this agenda and its impact by cultivating a series of transdisciplinary research partnerships, grounded in the social and behavioral sciences, to produce and report empirical insights about the arts for the benefit of arts and non-arts sectors alike. Each NEA Research Lab will define its own research agenda, conduct a research program to implement that agenda, and prepare reports that will contribute substantively to a wider understanding of one of three areas of special interest to the National Endowment for the Arts: 1. The Arts, Health, and Social/Emotional Well-Being a. Therapeutic Approaches and Benefits b. Non-Therapeutic Approaches and Benefits 2. The Arts, Creativity, Cognition, and Learning 3. The Arts, Entrepreneurship, and Innovation We anticipate that a sustained engagement with these topic areas, and with the corresponding research questions we frame below, will have distinctive benefits not only for the arts community, but also for sectors such as healthcare, education, and business or management.

Under the OVC FY 2017 Action Partnerships for National Membership, Professional Affiliation, and Community Service Organizations: Post-Conviction Services to Victims of Crime solicitation, applicants will be asked to address one or a combination of the following areas: Victim services throughout post-conviction involvement in criminal cases through appeal, parole, and psychiatric review hearings, etc.Unique issues in serving victims involved with cold cases (it is understood there may not be an actual conviction in these instances), capital cases, and/or wrongful conviction cases.Emerging issues such as retroactive legislation making necessary protocols for victim notification and other services and support.Provision of victim services through facilitated dialogue processes such as victim driven voluntary restorative justice programs and/or diversion programs or tribal peacemaking programs in lieu of conviction.Field-generated ideas or other issues related to post-conviction services not addressed above where applicants can effectively demonstrate a need or gap.

The primary mission of the Peter G. Dodge Foundation is to help people lead lives free from the effects of alcohol addiction. By increasing treatment options, elevating awareness, and facilitating access, the foundation works to create a new paradigm for what treatment and recovery can be. To advance this mission, the foundation is accepting applications for its Mission Grants program, which awards grants of up to $10,000 in support of programs that address alcohol-use disorder diagnosis (AUD) and referral to treatment; disseminate information about the full spectrum of treatment options that exist for AUD; help young people understand alcohol addiction and take action when it affects them; increase and update knowledge about AUD treatment in medical schools and among physicians; and/or develop or test new avenues for AUD treatment.

The purpose of this Brain Research through Advancing Innovative Neurotechnologies (BRAIN) Initiative is to encourage applications that will develop and validate tools and resources to facilitate the detailed analysis of brain microconnectivity. Novel and augmented techniques are sought that will ultimately be broadly accessible to the neuroscience community for the interrogation of microconnectivity in healthy and diseased brains of model organisms and humans. Development of technologies that will significantly drive down the cost of connectomics would enable routine mapping of the microconnectivity on the same individuals that have been analyzed physiologically, or to compare normal and pathological tissues in substantial numbers of multiple individuals to assess variability.  Advancements in both electron microscopy (EM) and super resolution light microscopic approaches are sought. Applications that propose to develop approaches that break through existing technical barriers to substantially improve current capabilities are highly encouraged. Proof-of-principle demonstrations and/or reference datasets enabling future development are welcome, as are improved approaches for automated segmentation and analysis strategies of neuronal structures in EM images.

In today's increasingly networked, distributed, and asynchronous world, cybersecurity involves hardware, software, networks, data, people, and integration with the physical world. However, society's overwhelming reliance on this complex cyberspace has exposed its fragility and vulnerabilities: corporations, agencies, national infrastructure and individuals have been victims of cyber-attacks. Achieving a truly secure cyberspace requires addressing both challenging scientific and ... More at https://www.nsf.gov/funding/pgm_summ.jsp?pims_id=504709&WT.mc_id=USNSF_39&WT.mc_ev=click

The McGovern Institute for Brain Research at the Massachusetts Institute of Technology was established in 2000 by Patrick J. McGovern and Lore Harp McGovern, with the goal of improving human welfare, communication, and understanding through their support for neuroscience research. The institute has announced a call for nominations for its twelfth annual Edward M. Scolnick Prize in Neuroscience. Now in its fifteenth year, the Scolnick Prize is designed to recognize outstanding advances in the field of neuroscience. The prize, which is endowed through a gift from Merck to the McGovern Institute, consists of a $150,000 award, plus an inscribed gift. In addition, the recipient will present a public lecture at the McGovern Institute in spring 2018. A gala dinner for the recipient and invited guests follows the prize lecture. Candidates for the award must be nominated by individuals affiliated with universities, hospitals, medicals schools, or research institutes, with a background in neuroscience. Self-nomination is not permitted.

The David Wechsler Early Career Grant for Innovative Work in Cognition supports early career psychologists pursuing innovative work in neuropsychology, intelligence and/or the assessment aspects of cognition. Those who work on positive applied neuropsychology are encouraged to apply. The grant is for up to $25,000.Applicants must: Be psychologists with an EdD, PsyD or PhD from an accredited university.Be no more than 10 years post doctoral.Have demonstrated competence and capacity to execute the proposed work.

The purpose of this research is to identify, implement, and evaluate the use of effective strategies and tools for provider and patient use to taper and/or discontinue opioids, benzodiazepines, and other medications in which risk outweighs benefits to prevent falls, overdose, and other injuries among community dwelling older adults.